In breast cancer (BC), for instance, overexpression of MAGI2-AS3 reduces the proliferation and migration of BC cells by downregulating DNA methylation of MAGI2 and blocking the Wnt/-catenin pathway (50). This evidence concerns the gene MAGI2 and breast carcinoma.